Insider Trading & Ownership - Gamelin Erick

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gamelin Erick

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-03-01
Option Award		2024-11-27
6:08 pm		N/A
2034-02-28		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Development Officer		45,045$045,045
(Direct)		View
2024-11-14
Tax Withholding		2024-11-18
4:29 pm		N/A
N/A		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Development Officer		402$7.9216,961
(Direct)		View
2024-08-14
Tax Withholding		2024-08-16
4:50 pm		N/A
N/A		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Development Officer		402$7.0217,363
(Direct)		View
2024-05-14
Tax Withholding		2024-05-16
6:58 pm		N/A
N/A		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Development Officer		402$8.3617,765
(Direct)		View
2024-02-14
Tax Withholding		2024-02-16
5:10 pm		N/A
N/A		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Development Officer		468$3.418,167
(Direct)		View
2023-11-14
Tax Withholding		2023-11-16
7:41 pm		N/A
N/A		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Medical Officer		1,395$5.0818,635
(Direct)		View
2022-11-14
Option Award		2022-11-16
7:21 pm		N/A
2032-11-13		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Medical Officer		80,120$080,120
(Direct)		View

Ownership		2022-11-09
8:30 pm		N/A
2031-03-24		Acrivon Therapeutics Inc.ACRVGamelin Erick
Chief Medical Officer		0$0162,206
(Direct)		View